Historical salary details - Ms. Karen A. Dawes, M.A., Independent Director, Medicenna Therapeutics Corp
Ms. Karen A. Dawes, M.A. is the Independent Director of Medicenna Therapeutics Corp. They also hold 1 other positions in and Repligen Corp..
Ms. Karen A. Dawes, M.A.
Independent Director
-
Gross Remuneration
-
Current Company
Medicenna Therapeutics Corp
| YEAR | COMPANY | POSITION | SALARY | INCREMENT |
|---|---|---|---|---|
| 2024 | Medicenna Therapeutics Corp | Independent Director | - | - |
| 2024 | Repligen Corp. | Lead Independent Director | - | - |
| 2023 | Repligen Corp. | Chairperson of the Board | 431.1 K | 12.9 % |
| 2023 | Medicenna Therapeutics Corp | Independent Director | 123.7 K | 2.2 % |
| 2022 | Repligen Corp. | Chairperson of the Board | 382.0 K | 2.5 % |
| 2022 | Medicenna Therapeutics Corp | Independent Director | 121.0 K | - |
| 2022 | Vaccitech plc - ADR | Independent Director | 112.0 K | - |
| 2022 | Barinthus Biotherapeutics Plc. - ADR | Independent Director | 112.0 K | -74.0 % |
| 2021 | Barinthus Biotherapeutics Plc. - ADR | Independent Director | 431.0 K | - |
| 2021 | Repligen Corp. | Chairperson of the Board | 372.5 K | 4.3 % |
| 2021 | PaxMedica Inc | Independent Director | 52.3 K | - |
| 2021 | Medicenna Therapeutics Corp | Independent Director | - | - |
| 2020 | Repligen Corp. | Chairperson of the Board | 357.2 K | 7.8 % |
| 2020 | Assertio Holdings Inc | - | 30.6 K | -88.6 % |
| 2020 | Barinthus Biotherapeutics Plc. - ADR | Director | - | - |
| 2020 | Assertio Holdings Inc | Independent Director | - | - |
| 2019 | Repligen Corp. | Chairperson of the Board | 331.3 K | -0.1 % |
| 2019 | Assertio Holdings Inc | Independent Director | 267.4 K | 1.5 % |
| 2019 | PaxMedica Inc | Independent Director | - | - |
| 2018 | Repligen Corp. | Chairman of the Board | 331.5 K | 20.4 % |
| 2018 | Assertio Holdings Inc | Independent Director | 263.5 K | 36.5 % |
| 2017 | Repligen Corp. | Chairman of the Board | 275.3 K | -65.8 % |
| 2017 | Assertio Holdings Inc | Independent Director | 193.0 K | -4.7 % |
| 2016 | Repligen Corp. | Chairman of the Board | 805.7 K | 200.0 % |
| 2016 | Assertio Holdings Inc | Independent Director | 202.5 K | 0.0 % |
| 2015 | Repligen Corp. | Chairman of the Board | 268.6 K | -21.2 % |
| 2015 | Assertio Holdings Inc | Independent Director | 202.5 K | -2.9 % |
| 2014 | Repligen Corp. | Chairman of the Board | 340.9 K | 101.7 % |
| 2014 | Assertio Holdings Inc | Independent Director | 208.4 K | 54.6 % |
| 2013 | Repligen Corp. | Chairman of the Board | 169.0 K | 10.1 % |
| 2013 | Assertio Holdings Inc | Independent Director | 134.8 K | 5.1 % |
| 2012 | Repligen Corp. | Chairman of the Board | 153.5 K | 132.8 % |
| 2012 | Assertio Holdings Inc | Independent Director | 128.3 K | 7.2 % |
| 2011 | Assertio Holdings Inc | Independent Director | 119.7 K | 39.3 % |
| 2011 | Repligen Corp. | - | 79.4 K | -25.0 % |
| 2011 | Repligen Corp. | Chairman of the Board | 65.9 K | -37.7 % |
| 2010 | Repligen Corp. | Director | 105.9 K | -2.0 % |
| 2010 | Assertio Holdings Inc | Independent Director | 86.0 K | 34.2 % |
| 2009 | Repligen Corp. | Director | 108.1 K | 3.6 % |
| 2009 | Assertio Holdings Inc | Director | 64.0 K | 101.4 % |
| 2008 | Repligen Corp. | Director | 104.3 K | 6.7 % |
| 2008 | Assertio Holdings Inc | Director | 31.8 K | - |
| 2007 | Repligen Corp. | Director | 97.8 K | - |
| 2007 | Assertio Holdings Inc | Director | - | - |
| 2006 | Repligen Corp. | Director | - | - |
| 2005 | Repligen Corp. | Director Nominee | - | - |